Health committee  As we shared with you, we are here today because we find the PMPRB consultative process to be ineffective. The feedback provided by not just us but patient organizations has been ignored, as is reflected in the number of significant increases in the number of negative submissions

Health committee  One thing we find as we are working with indigenous communities as well is that they are even more challenged with regard to optimal access during the time of COVID. Just this morning, for instance, I had a discussion with Greybox, which is a Quebec-based virtual technology dig

Health committee  Thank you for that question, honourable member. There's a process in place in Canada that has been in place for 10 years, which the provinces have implemented. It is called, as you are aware, the pan-Canadian pharmaceutical alliance. Boehringer Ingelheim was the first company th

Health committee  In any business, honourable member, you require certainty and predictability over a three- to five-year horizon. Introducing a drug in Canada requires investments in clinical trials. It requires more than just getting a Health Canada approval. What has happened with the PMPRB r

Health committee  Thank you for asking—

Health committee  No. If I could share with you, Mr. Davies—

Health committee  I will leave it up to Annie. Did you want to address that?

Health committee  I'm sorry. I was muted.

Health committee  Thank you for the question, honourable member. All you have to do is take a look at what's transpired since 2018 when the PMPRB guidelines were initially put out, from the perspective of clinical trials and from the perspective of new drug launches in Canada. Of 34 drug launches

Health committee  The pharmaceutical industry plans long term—three to five years—in the clinical trials that we establish in any jurisdiction, in the kind of health system partnerships we establish in Canada, and in patient support programs to take care of patients who may fall between the gaps.

Health committee  I would say that, if you take a look at the submissions that the patient organizations have made—

Health committee  Thank you, Annie. Thank you, Mr. Chair, and honorary members as well. As a demonstration of our commitment to work with Canadians to solve problems that result in optimized outcomes, for the past three years we have been working with an indigenous-led health policy group to de